Vaccinex Inc.

0.60
-0.16 (-21.05%)
At close: Apr 03, 2025, 12:23 PM

Vaccinex Statistics

Share Statistics

Vaccinex has 2.68M shares outstanding. The number of shares has increased by 68.95% in one year.

Shares Outstanding 2.68M
Shares Change (YoY) 68.95%
Shares Change (QoQ) 0%
Owned by Institutions (%) 0%
Shares Floating 1.15M
Failed to Deliver (FTD) Shares 15
FTD / Avg. Volume 0.36%

Short Selling Information

The latest short interest is 62.11K, so 2.32% of the outstanding shares have been sold short.

Short Interest 62.11K
Short % of Shares Out 2.32%
Short % of Float 6.65%
Short Ratio (days to cover) 0.6

Valuation Ratios

The PE ratio is -0.21 and the forward PE ratio is -8.5. Vaccinex's PEG ratio is 0.

PE Ratio -0.21
Forward PE -8.5
PS Ratio 7.52
Forward PS 0
PB Ratio -1.85
P/FCF Ratio -0.25
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Vaccinex.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of -0.11.

Current Ratio 0.57
Quick Ratio 0.57
Debt / Equity -0.11
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage -22885

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $15.41K
Profits Per Employee $-547.32K
Employee Count 37
Asset Turnover 0.16
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -91.19% in the last 52 weeks. The beta is 1.35, so Vaccinex's price volatility has been higher than the market average.

Beta 1.35
52-Week Price Change -91.19%
50-Day Moving Average 0.95
200-Day Moving Average 3.32
Relative Strength Index (RSI) 41.14
Average Volume (20 Days) 4.18K

Income Statement

In the last 12 months, Vaccinex had revenue of 570K and earned -20.25M in profits. Earnings per share was -43.68.

Revenue 570K
Gross Profit 570K
Operating Income -22.89M
Net Income -20.25M
EBITDA -19.75M
EBIT -19.87M
Earnings Per Share (EPS) -43.68
Full Income Statement

Balance Sheet

The company has 1.53M in cash and 247K in debt, giving a net cash position of 1.29M.

Cash & Cash Equivalents 1.53M
Total Debt 247K
Net Cash 1.29M
Retained Earnings -339.93M
Total Assets 4.85M
Working Capital -1.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.23M and capital expenditures -67K, giving a free cash flow of -17.3M.

Operating Cash Flow -17.23M
Capital Expenditures -67K
Free Cash Flow -17.3M
FCF Per Share -37.31
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -4014.91% and -3552.81%.

Gross Margin 100%
Operating Margin -4014.91%
Pretax Margin -3552.81%
Profit Margin -3552.81%
EBITDA Margin -3464.56%
EBIT Margin -4014.91%
FCF Margin -3035.26%

Dividends & Yields

VCNX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for VCNX.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Feb 20, 2024. It was a backward split with a ratio of 1:14.

Last Split Date Feb 20, 2024
Split Type backward
Split Ratio 1:14

Scores

Altman Z-Score -115.22
Piotroski F-Score 4